August 05th, 2023

Some of the companies expected to report financial results on Tuesday, August 8, are: Zoetis Inc. (NYSE: ZTS), a frontrunner in animal health solutions, is set to announce its financial results before the opening of the market.  Analysts a. Read more

August 05th, 2023

As the financial reporting season heats up, a number of companies are poised to reveal their second-quarter 2023 results, offering insights into their performance and market trends. The lineup for Monday, August 7, includes: KKR & Co. Inc. (NYSE: . Read more

August 05th, 2023

Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) have received U.S. Food and Drug Administration (FDA) approval for ZURZUVAE (zuranolone) 50 mg, offering a groundbreaking 14-day oral treatment for postpartum depression (PPD) in a. Read more

August 04th, 2023

Shares of ManpowerGroup Inc. (NYSE: MAN) surged in after-hours trading following the company's announcement that its Board of Directors has greenlit a fresh share buyback program of up to 5.0 million shares of its common stock, which will be executed. Read more

August 04th, 2023

President Joe Biden hailed the latest employment report as a testament to the success of his economic policies, commonly referred to as Bidenomics. With unemployment reaching a record low and the proportion of employed working-age Americans hitting a. Read more

August 04th, 2023

AMC Networks Inc. (Nasdaq: AMCX) reported Q2 2023 adjusted earnings per share (EPS) of $2.02, surpassing analysts' expectations of $1.60.  However, the company reported quarterly revenues of $678.63 million, falling short of the consensus est. Read more

August 04th, 2023

Fluor Corporation (NYSE: FLR) has reported adjusted earnings per share (EPS) of $0.76 for the second quarter of 2023, with revenues totaling $3.94 billion. These results significantly surpassed the consensus estimate of $0.43 EPS on revenues of $3.68. Read more

August 04th, 2023

Mesoblast Limited (Nasdaq: MESO) has announced the receipt of a comprehensive response from the US Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) resubmission for remestemcel-L. The FDA's response stipulates the . Read more

August 03rd, 2023

Shares of Booking Holdings Inc. (Nasdaq: BKNG) experienced a remarkable after-hours surge of over 10% following the release of its second-quarter 2023 financial results. The company outperformed expectations with an earnings per share (EPS) of $37. Read more

August 03rd, 2023

FOR IMMEDIATE RELEASE 2023-146 Washington D.C. / CRWE PRESS RELEASE / Aug. 3, 2023 -  The Securities and Exchange Commission today announced that it obtained a temporary asset freeze, restraining order, and other emergency relief agains. Read more